Industry Analysis & Industry Trends
The Pain Medication OTC Manufacturing industry manufactures pharmaceutical products that focus on pain relief and are available without a doctor's permission. As a country with a high awareness of medication and self-medication uses, domestic demand for OTC pain medication has remained healthy over the past five years. This is despite a cautious consumer environment in which consumers have attempted to focus spending on high-value items.
Local manufacturing operations have struggled to benefit from this trend. Global pharmaceutical manufacturing has shifted production towards Asia, where labour is cheaper and the plants are larger, leading to substantial increases in economies of scale. With these jumps in production capacity, import competition has increased substantially... purchase to read more
Industry Report - Industry Key Buyers Chapter
The Pain Medication OTC Manufacturing industry in Australia exhibits a medium level of market share concentration. The top four companies account for approximately 50.0% of the industry. GSK and Pfizer Australia dominate the industry, significantly more so than other pharmaceutical manufacturing industry. This is due to many global pharmaceutical companies offshoring to cut costs because of increased import pressure. As a result, a large proportion of industry goods are imported into Australia.
In the generic drug-manufacturing sector, the level of concentration is significantly lower. This is because a large number of generic drug makers solely manufacture drugs, branding them as their chemical compounds and with little to no attempt at marketing to minimise costs... purchase to read more